Tag Archives: CKD

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

Chronic kidney disease is associated with age-related renal function decline accelerated in hypertension, diabetes, obesity and primary renal disorders. Cardiovascular disease is the primary cause of morbidity and mortality where CKD is regarded as an accelerator …

Read more »
Posted in Nephrology, Primary Care | Also tagged , | Leave a comment

Quick Case: Intracranial Bleed

By: Dr. Pragnesh Vachharajani, MBBS, PGDMCH
Sudden increase in blood pressure at times can be dangerous. It can lead to bleeding anywhere in the body. Smooth control of blood pressure is a must for all. Regular monitoring is also mandatory. In this patient, a stable CKD patient, possible sudden increase in blood pressure lead to intracranial…

Read more »
Posted in Case Studies | Also tagged , | Volume: | Leave a comment

Is chronic kidney disease a coronary heart disease risk equivalent?

Patients with chronic kidney disease (CKD) have an increased risk of myocardial infarction (MI) and a higher MI mortality rate as compared with patients diagnosed with diabetes or who have had a prior MI event, according to a recently published study. “Chronic kidney disease in India is a public health… 

Read more »
Posted in Cardiovascular, Non-Communicable Disease, Primary Care | Also tagged , , , , , , , , , , , , , , | Volume: | Leave a comment

Chronic kidney disease underdiagnosed in patients with type 2 diabetes

mdCurrent Conference Report: 72nd Annual Scientific Sessions of the American Diabetes Association. Chronic kidney disease (CKD) is significantly underdiagnosed in the population with type 2 diabetes, say investigators who conducted a recent multi-site observational cross-sectional study. This is an especially important finding for Indian physicians and patients, since the International Diabetes… 

Read more »
Posted in Diabetes, Primary Care | Also tagged , , , , , , , , , , , , , | Volume: | 2 Responses

Meta-analyses: Aspirin’s utility in chronic kidney disease isn’t clear

An increase in the risk of bleeding may nullify the benefits of antiplatelet therapy in patients with chronic kidney disease (CKD), according to a pair of meta-analyses. The evidence from clinical trials included in the meta-analyses is of low quality, the authors reported, with numerous limitations. “Bleeding hazards and lack… 

Read more »
Posted in Cardiovascular Disease, Diabetes, Nephrology, Pharmacology, Primary Care | Also tagged , , , , , , , | Volume: | Leave a comment